Whatever You're Into, Get Into Vaccine Pandemic

A living thing that has exhibited the characteristic of thriving on the expense of some other living being, better than humans, as far as I can think of, might only be viruses. Sickness has existed as long as humans have, which has brought forward the need for medicines in human society, oldest use of prescriptions dates back to 2,112 BC – 2,004 BC in Sumer during the third dynasty of Ur.

But the way we handle sickness now is completely different from how we went about it in the medieval times. Yes, the credit is unanimously given to science and technology but what really deserves the credit for our development must be the undying human tendency to know and learn, be it John Snow, who traced the source of cholera outbreak in London,or Edward Jenner, who found out that infection to cow pox could create immunity to small pox, in a period when it was considered that demons and other “sinful airs were disseminating diseases. Throughout history, humankind has benefitted from such individuals who have from their curiosity contributed to the world we live in today.





Of course, we can praise technology for all the comforts it has given to us on a livelong day. But what we have given it as quid pro quo is something of exceeding importance and as Simon Sinek puts it in his Millennial Question, one of four, pressing issues of this generation: patience. Every comfort, knowledge and even service is as far away as our fingertips. What this has done is that now everyone believes that everything is achievable in an instant, largely due to the fact that the time and effort put into making something is not visible, and it is times like these that show us how vital patience really is. It has been more than thirty years and still there is no cure for HIV, its first reported case goes back to 1984. One thing that is clear is that making vaccines is cumbersome and a tedious process.

For the uninitiated vaccine development is split into three phases : 

Exploratory phase: Wherein scientists use different approaches of developing a testable vaccine. 

Clinical trials: In this phase the vaccines are evaluated on its safety, efficacy and side-effects across different populations. This phase is generally the least flexible. 

Manufacturing: Mass production of vaccines to be used around the world. The process of manufacturing vaccines goes hand in hand with the first two phases as the process of developing each vaccine is typical and cannot be replicated. From a bit of research and optimism it is believed that in future it would be possible to swap the genetic material from different vaccines as per our needs but for now, we have to suffice with what we have.

Normally this process takes up around 15-20 years considering the time and money spent on research and development. But desperate times require desperate measuresand scientists pull various strings to get through each stage as quickly as possible. The exploratory phase allows maximum flexibility. The goal of this phase is to find a way so as to safely inject the vaccine into our system and giving our bodies the time and information, it needs to create the antibodies which fight off the infection.
There are many ways to invoke our immune system to respond to the vaccine without getting overwhelmed by the surge of the foreign particles injected into our system and there is no telling as to which one would work in our bodies. One of the more traditional methods being attenuated vaccine which develops a long-lasting resilience but its development consumes immense amount of time. The other popular method of preparation of vaccine being the inactivatedvaccine method wherein the virus is subjected to heat, acid, radioactivity and other changes in pressure and temperature. But the catch is, being testable does not deem a vaccine to be successful in curbing the disease, and an unsuccessful attempt means starting from scratch. To avoid these obstacles labs from all around the world work with coordination and unison, with each trying different methods simultaneously so as to develop the most effective way of producing vaccine.
This approach resulted in the first vaccine of Zika virus in just 7 months, when it the virus ravaged in Latin America in 2016 and the first Coronavirus vaccine in just 42 days.



The US,has moved with great speed, which is not a surprise with the way the virus is devouring the nation. One of its pharma giants, Pfizer and its German counterpart have begun human trials and Modernahas begun phase-3 trials of its m-RNA-1273 vaccine. China, has also decided not to stay behind in the race to develop a vaccine, with fiveof its vaccines in human trials phase.

But, amongst these global super-powers how is India faring?

We can criticize India for all the shady politics, the education system, even the media, but trust me, we’ve never been more thankful to hear that India is the largest producer of vaccines in the world, manufacturing about 60% - 70% vaccines.The Pune based Serum Institute of India has tied up with many pharma giants all over the world such as UK’s AstraZeneca, USA’s Codagenix, Austria’s Themisto name a few. In an interview, the CEO of SII has claimed that they plan to bring the vaccine to low and middle-income nations. Zydus Cadila, based in Ahmedabad has also jumped into the race and was previously engaged in making rapid diagnostic kits. Even Bharat Biotech International Ltd. has begun clinical testing of developing a vaccine that is indigenous to India. Apart from these, Mynvax and Indian Immunological Ltd. are also using their grey cells for developing a vaccine.


What’s next?

With number of cases peaking and, in a country, where population soars as high as the cupidity of its politicians, following the norms of physical distancing is virtually impossible, a suitable vaccine is the need of the hour! And of course, a conscious effort on the part of the public to do their duty as a citizen of the nation by following the norms of physical distancing, which seems pretty unlikely.A few antivirals have entered into the limelight to fight against coronavirus, Favipiravir, which was invented back in the 90’s to counter influenza in Japan, has been commissioned to be sold in India for treating patients with mild COVID symptoms. This strengthens our optimism that this disease can be conquered, all we have to do is to be patient until this storm wears off.









Comments

Post a Comment

Popular posts from this blog

A Long Haul towards Safety

Ignorance Of The Educated

How Was Smallpox Eradicated ??

Why Most People Shy from Public Hospitals? (A 5 minute Read ...)

Is Contact Tracing App A key to your Privacy?